Pre-Open Stock Movers 12/15: (QNRX) (GMTX) (GRTX) Higher; (RBLX) (LESL) (MGNI) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Legend Biotech (LEGN) Prices 7.5M Share Offering at $40/sh
December 16, 2021 9:19 AM ESTLegend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it has priced an underwritten public offering of 7,500,000 American depositary shares (ADSs), each representing two ordinary shares, at a public offering price of $40.00 per ADS, for total gross proceeds of approximately $300.0 million. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being... More
Lowe's (LOW) PT Raised to $300 at Jefferies
December 16, 2021 7:51 AM ESTJefferies analyst Jonathan Matuszewski raised the price target on Lowe's (NYSE: LOW) to $300.00 (from $290.00) while maintaining a Buy rating.
The analyst commented, "We're not surprised management expects home improvement industry spend to fall in '22 after record-setting growth in '20 & '21. While... More
